Ondansetron

Product NDC
17856-4091
11-digit product format
178564091
Labeler code
17856
Product ID
17856-4091_25fc2f67-72d9-4170-ac0c-5519cfed31bc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ondansetron
Dosage form
SOLUTION
Route
ORAL
Labeler
Atlantic Biologicals Corps
Application
ANDA091483
Marketing category
ANDA
Marketing start
2010-12-17
Marketing end
0000-00-00
Substance
ONDANSETRON HYDROCHLORIDE
Active strength
4 mg/5mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d9bd4853-037c-6968-f4d4-9bb9a0efd1eaProduct name220250722
32e23bc9-ce14-4555-bb6d-bcb654d7d296Product name120201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49Product name120201015
909480fe-0d18-c1c1-a658-0bd9a7131822Product name520170829
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
17856-4091-32020-01-31C16284748780-19d75b9d1-0ae0-f424-e053-dadaa90a57ceOndansetron Oral Solution, USP 4 MG/5 ML

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-4091-3Ondansetron5 mL in 1 CUPSOLUTION52

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ONDANSETRON HYDROCHLORIDEACTIVE INGREDIENTNMH84OZK2BONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SACCHARIN SODIUM DIHYDRATEINACTIVE INGREDIENTSB8ZUX40TYONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
STRAWBERRYINACTIVE INGREDIENT4J2TY8Y81VONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2
WATERINACTIVE INGREDIENT059QF0KO0RONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-4091ONDANSETRON SOLUTION [ATLANTIC BIOLOGICALS CORPS]2Legacy NDC, 1 package rows20120928_7a3c9566-1847-4867-b528-0e91fb8bab94.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312085ondansetron HCl 4 MG in 5 mL Oral SolutionPSN7a3c9566-1847-4867-b528-0e91fb8bab942
312085ondansetron 0.8 MG/ML Oral SolutionSCD7a3c9566-1847-4867-b528-0e91fb8bab942
312085ondansetron (as ondansetron HCl dihydrate) 4 MG per 5 ML Oral SolutionSY7a3c9566-1847-4867-b528-0e91fb8bab942
312085ondansetron 4 MG per 5 ML Oral SolutionSY7a3c9566-1847-4867-b528-0e91fb8bab942

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
17856-4091-3178564091035 mL in 1 CUP5 mlHistorical